1-3 of 3
Kunju J Sridhar, PhD
Close
Sort by
Journal Articles

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Gregory K. Behbehani, MD PhD, Rachel Finck, B.S., Nikolay Samusik, PhD, Pier Federico Gherardini, PhD, Kunju J Sridhar, PhD, Wendy J. Fantl, PhD, Peter L. Greenberg, MD, Garry P. Nolan, PhD
Journal: Blood
Blood (2014) 124 (21): 1903.
https://doi.org/10.1182/blood.V124.21.1903.1903
Published: 2014
Journal Articles

A Novel Nano-Immunoassay (NIA) Reveals Inhibition of PI3K and MAPK Pathways in CD34+ Bone Marrow Cells of Patients with Myelodysplastic Syndrome (MDS) Treated with the Multi-Kinase Inhibitor On 01910.Na (Rigosertib),

Alice C Fan, MD, Liwen Xu, PhD, Kunju J Sridhar, PhD, Mai Tran, Prajna Banerjee, PhD, John P. Renschler, Radha Tripuraneni, MD, Francois Wilhelm, MD, PhD., Peter L. Greenberg, MD, Dean W. Felsher, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3808.
https://doi.org/10.1182/blood.V118.21.3808.3808
Published: 2011
Journal Articles

In Situ Tissue Microarray Cell-Lineage Specific Analysis of Protein Expression In Intact Myelodysplastic Bone Marrow: Data on Putative Poor Prognosis Biomarkers

Dita Gratzinger, MD, PhD, Justin I Odegaard, MD, PhD, Robert J Marinelli, PhD, Kunju J Sridhar, PhD, Peter L. Greenberg, MD
Journal: Blood
Blood (2010) 116 (21): 1887.
https://doi.org/10.1182/blood.V116.21.1887.1887
Published: 2010